(secondQuint)The Clinical Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months Treatment.

 This study will enroll 100 cases of refractory rheumatoid arthritis (RA) patients in Chinese,who are in moderate or severe disease activity and insufficiency response or intolerance to DMARDs.

 The participants plan to be treated with Tacrolimus alone, or along with methotrexate (MTX) if participants were tolerant to MTX.

 The efficacy and safety of 6 month Tacrolimus treatment in RA patients will be evaluated with DAS28 and other disease activity indices.

.

 The Clinical Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months Treatment@highlight

This study is designed to observed prospectively the efficacy and safety of 6 months treatment of Tacrolimus alone or with methotrexate (MTX) in moderate and severe Chinese RA patients who shown insufficiency response or intolerance to DMARDs